Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Gross Profit (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Gross Profit data on record, last reported at $293.0 million in Q4 2025.

  • For Q4 2025, Gross Profit rose 17.2% year-over-year to $293.0 million; the TTM value through Dec 2025 reached $994.0 million, up 3.87%, while the annual FY2025 figure was $994.0 million, 3.87% up from the prior year.
  • Gross Profit reached $293.0 million in Q4 2025 per INDV's latest filing, up from $230.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $293.0 million in Q4 2025 and bottomed at $220.0 million in Q2 2024.